Literature DB >> 10196602

Estimation of expected utility gained from the helmet law in Taiwan by quality-adjusted survival time.

J Y Tsauo1, J S Hwang, W T Chiu, C C Hung, J D Wang.   

Abstract

The objective of this study was to empirically estimate the expected utility gained from the implementation of the 1997 helmet law in Taiwan by using quality-adjusted survival time (QAST). We randomly selected 400 out of 8221 registered cases of head injury and successfully interviewed 99 cases with the index of health-related quality of life (IHRQ). The function of IHRQ was then multiplied with the corresponding survival function to obtain the QAST for head injury. The total utility gained from the helmet law in Taipei within 1 year was estimated by multiplying the expected loss of utility per patient with the number of prevented cases. The results showed that after 80 months of follow-up, the QAST of the injured population was 66.3 quality-adjusted life-months (QALMs), while that of the reference population was 78.7 QALMs. We extrapolated the QAST for total life expectancy by simulating the survival of head injury cases using the life table data from the general population. The life-long utility loss of a head injury case was found to be 4.8 quality-adjusted life-years (QALY). The number of prevented cases during the first year of enforcement of the helmet law was estimated to be 1300 cases in Taipei, which amounted to 6240 QALYs gained. For lack of data, we were unable to calculate the possible gain from helmet on reduction of severity among nonfatal cases with head injury, and the estimation was only a lower bound. We concluded that the QAST approach is a feasible approach applicable to health policy decision-making, especially in cost-utility analysis.

Entities:  

Mesh:

Year:  1999        PMID: 10196602     DOI: 10.1016/s0001-4575(98)00078-5

Source DB:  PubMed          Journal:  Accid Anal Prev        ISSN: 0001-4575


  7 in total

Review 1.  Universal Motorcycle Helmet Laws to Reduce Injuries: A Community Guide Systematic Review.

Authors:  Yinan Peng; Namita Vaidya; Ramona Finnie; Jeffrey Reynolds; Cristian Dumitru; Gibril Njie; Randy Elder; Rebecca Ivers; Chika Sakashita; Ruth A Shults; David A Sleet; Richard P Compton
Journal:  Am J Prev Med       Date:  2017-06       Impact factor: 5.043

2.  Survival-weighted health profile for long-term survivors of acute myelogenous leukemia.

Authors:  Chiun Hsu; Jung-Der Wang; Jing-Shiang Hwang; Hwei-Fang Tien; Shueh-Mei Chang; Ann-Lii Cheng; Yao-Chang Chen; Jih-Luh Tang
Journal:  Qual Life Res       Date:  2003-08       Impact factor: 4.147

3.  Quality-adjusted life-years and helmet use among motorcyclists sustaining head injuries.

Authors:  Hsin-Yi Lee; Yeh-Hsin Chen; Wen-Ta Chiu; Jing-Shiang Hwang; Jung-Der Wang
Journal:  Am J Public Health       Date:  2010-01       Impact factor: 9.308

4.  Social inequality in motorcycle helmet use: when a reduction in inequality is not necessarily good news.

Authors:  Shu-Ti Chiou; Tsung-Hsueh Lu; Ching-Huei Lai; Tung-Liang Chiang; Ichiro Kawachi
Journal:  J Epidemiol Community Health       Date:  2014-03-27       Impact factor: 3.710

5.  Informing road traffic intervention choices in South Africa: the role of economic evaluations.

Authors:  Hadley K H Wesson; Nkuli Boikhutso; Adnan A Hyder; Melanie Bertram; Karen J Hofman
Journal:  Glob Health Action       Date:  2016-07-06       Impact factor: 2.640

Review 6.  Health State Preference Weights for the Glasgow Outcome Scale Following Traumatic Brain Injury: A Systematic Review and Mapping Study.

Authors:  Gordon Ward Fuller; Monica Hernandez; David Pallot; Fiona Lecky; Mathew Stevenson; Belinda Gabbe
Journal:  Value Health       Date:  2016-12-28       Impact factor: 5.725

7.  Predicting the Health-related Quality of Life in Patients Following Traumatic Brain Injury.

Authors:  Thara Tunthanathip; Thakul Oearsakul; Pimwara Tanvejsilp; Sakchai Sae-Heng; Anukoon Kaewborisutsakul; Suphavadee Madteng; Srirat Inkate
Journal:  Surg J (N Y)       Date:  2021-06-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.